Search research articles
Contact Us
Filters
Showing results (231-240 of 243) with videos related to
Page
of 25
Sort By:
Nihon Gan Chiryo Gakkai Shi
|
June 20, 1990
[The preoperative and postoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of gastric cancer. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer]
J Sakamoto, H Nakazato, T Toge, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 30, 1998
[An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)]
T Taguchi, K Morimoto, N Horikoshi, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1991
Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas
H Kuniyasu, K Yoshida, H Yokozaki, et al.
British Journal of Cancer
|
January 1, 1997
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications
K Yoshida, T Sugino, S Goodison, et al.
International Journal of Cancer
|
July 17, 1997
Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential
K Aogi, M Nishiyama, R Kim, et al.
International Journal of Oncology
|
May 12, 2011
Immunohistochemical detection of cripto-1, amphiregulin and transforming growth-factor-alpha in human gastric carcinomas and intestinal metaplasias
T Saeki, D Salomon, N Normanno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 14, 1997
[Current status of low-dose CDDP. 5-FU therapy for solid malignant tumors--nationwide questionnaire survey]
S Saji, K Aiba, H Araki, et al.
Breast Cancer Research and Treatment
|
November 26, 1999
Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer
K Sugimachi, Y Maehara, K Akazawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 3, 1998
[Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer]
H Koyama, I Adachi, T Tajima, et al.
Surgical Oncology
|
June 1, 1996
Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan
J Sakamoto, H Nakazato, S Teramukai, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 243) with videos related to
Sort By:
Page
of 25
Nihon Gan Chiryo Gakkai Shi
|
June 20, 1990
[The preoperative and postoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of gastric cancer. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer]
J Sakamoto, H Nakazato, T Toge, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 30, 1998
[An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)]
T Taguchi, K Morimoto, N Horikoshi, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1991
Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas
H Kuniyasu, K Yoshida, H Yokozaki, et al.
British Journal of Cancer
|
January 1, 1997
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications
K Yoshida, T Sugino, S Goodison, et al.
International Journal of Cancer
|
July 17, 1997
Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential
K Aogi, M Nishiyama, R Kim, et al.
International Journal of Oncology
|
May 12, 2011
Immunohistochemical detection of cripto-1, amphiregulin and transforming growth-factor-alpha in human gastric carcinomas and intestinal metaplasias
T Saeki, D Salomon, N Normanno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 14, 1997
[Current status of low-dose CDDP. 5-FU therapy for solid malignant tumors--nationwide questionnaire survey]
S Saji, K Aiba, H Araki, et al.
Breast Cancer Research and Treatment
|
November 26, 1999
Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer
K Sugimachi, Y Maehara, K Akazawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 3, 1998
[Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer]
H Koyama, I Adachi, T Tajima, et al.
Surgical Oncology
|
June 1, 1996
Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan
J Sakamoto, H Nakazato, S Teramukai, et al.
Page
of 25